Allergy 0 7 0 7 B-treatment
desensitization 8 23 8 23 I-treatment
injections 24 34 24 34 I-treatment

Any 0 3 35 38 O
investigational 4 19 39 54 B-treatment
therapeutic 20 31 55 66 I-treatment
medication 32 42 67 77 I-treatment

Bone 0 4 78 82 O
marrow 5 11 83 89 O
: 11 12 89 90 O
ANC 13 16 91 94 B-clinical_variable
> 17 18 95 96 O
1,000/µ 19 26 97 104 B-lower_bound

Concurrent 0 10 105 115 O
treatment 11 20 116 125 O
or 21 23 126 128 O
medications 24 35 129 140 O
( 36 37 141 142 O
must 37 41 142 146 O
be 42 44 147 149 O
off 45 48 150 153 O
for 49 52 154 157 O
at 53 55 158 160 O
least 56 61 161 166 O
1 62 63 167 168 B-lower_bound
week 64 68 169 173 I-lower_bound
) 68 69 173 174 O

Creatinine 0 10 175 185 B-clinical_variable
clearance 11 20 186 195 I-clinical_variable

Documented 0 10 196 206 O
negative 11 19 207 215 O
serum 20 25 216 221 O
beta 26 30 222 226 O
- 30 31 226 227 O
HCG 31 34 227 230 O
for 35 38 231 234 O
female 39 45 235 241 B-gender
patients 46 54 242 250 I-gender
who 55 58 251 254 O
are 59 62 255 258 O
post 63 67 259 263 O
- 67 68 263 264 O
menarchal 68 77 264 273 O

Growth 0 6 274 280 O
factors 7 14 281 288 O
( 15 16 289 290 O
e.g. 16 20 290 294 O
Procrit 21 28 295 302 B-treatment
® 28 29 302 303 O
, 29 30 303 304 O
Aranesp 31 38 305 312 B-treatment
® 38 39 312 313 O
, 39 40 313 314 O
Neulasta 41 49 315 323 B-treatment
® 49 50 323 324 O
) 50 51 324 325 O

HIV 0 3 326 329 B-chronic_disease
- 3 4 329 330 O
positive 4 12 330 338 O
patients 13 21 339 347 O

HLA 0 3 348 351 B-clinical_variable
- 3 4 351 352 I-clinical_variable
A2 4 6 352 354 I-clinical_variable
positive 7 15 355 363 O
based 16 21 364 369 O
on 22 24 370 372 O
flow 25 29 373 377 O
cytometry 30 39 378 387 O

Hemoglobin 0 10 388 398 B-clinical_variable
> 11 12 399 400 O
8 12 13 400 401 B-lower_bound
g 14 15 402 403 I-lower_bound
/ 15 16 403 404 I-lower_bound
dl 16 18 404 406 I-lower_bound
( 19 20 407 408 O
may 20 23 408 411 O
be 24 26 412 414 O
transfused 27 37 415 425 O
) 37 38 425 426 O

Hepatic 0 7 427 434 O
: 7 8 434 435 O
bilirubin 9 18 436 445 B-clinical_variable
< 19 20 446 447 O
1.5x 21 25 448 452 B-upper_bound
institutional 26 39 453 466 I-upper_bound
normal 40 46 467 473 I-upper_bound
for 47 50 474 477 O
age 51 54 478 481 B-age

Interferon 0 10 482 492 B-treatment
( 11 12 493 494 O
e.g. 12 16 494 498 O
Intron 17 23 499 505 B-treatment
- 23 24 505 506 I-treatment
A 24 25 506 507 I-treatment
® 25 26 507 508 I-treatment
) 26 27 508 509 O

Interleukins 0 12 510 522 B-clinical_variable
( 13 14 523 524 O
e.g. 14 18 524 528 O
Proleukin 19 28 529 538 B-treatment
® 28 29 538 539 O
) 29 30 539 540 O

Karnofsky 0 9 541 550 B-clinical_variable
if 10 12 551 553 O
> 13 14 554 555 O
16 15 17 556 558 O
years 18 23 559 564 O
and 24 27 565 568 O
Lansky 28 34 569 575 B-clinical_variable
if 35 37 576 578 O
≤ 38 39 579 580 O
16 40 42 581 583 O
years 43 48 584 589 O
of 49 51 590 592 O
age 52 55 593 596 B-age

No 0 2 597 599 O
overt 3 8 600 605 B-chronic_disease
cardiac 9 16 606 613 I-chronic_disease
, 16 17 613 614 O
gastrointestinal 18 34 615 631 B-chronic_disease
, 34 35 631 632 O
pulmonary 36 45 633 642 B-chronic_disease
or 46 48 643 645 O
psychiatric 49 60 646 657 B-chronic_disease
disease 61 68 658 665 I-chronic_disease

Patients 0 8 666 674 O
may 9 12 675 678 O
have 13 17 679 683 O
tumor 18 23 684 689 B-cancer
spread 24 30 690 696 I-cancer
within 31 37 697 703 I-cancer
the 38 41 704 707 I-cancer
CNS 42 45 708 711 I-cancer

Patients 0 8 712 720 O
may 9 12 721 724 O
not 13 16 725 728 O
have 17 21 729 733 O
received 22 30 734 742 O
radiation 31 40 743 752 B-treatment
therapy 41 48 753 760 I-treatment
to 49 51 761 763 O
the 52 55 764 767 O
index 56 61 768 773 B-cancer
lesion 62 68 774 780 I-cancer
within 69 75 781 787 O
1 76 77 788 789 B-upper_bound
year 78 82 790 794 I-upper_bound
of 83 85 795 797 O
enrollment 86 96 798 808 O

Patients 0 8 809 817 O
may 9 12 818 821 O
not 13 16 822 825 O
have 17 21 826 830 O
received 22 30 831 839 O
radiation 31 40 840 849 B-treatment
to 41 43 850 852 O
the 44 47 853 856 O
index 48 53 857 862 O
lesion 54 60 863 869 O
within 61 67 870 876 O
1 68 69 877 878 B-upper_bound
year 70 74 879 883 I-upper_bound
of 75 77 884 886 O
enrollment 78 88 887 897 O

Patients 0 8 898 906 O
must 9 13 907 911 O
be 14 16 912 914 O
at 17 19 915 917 O
least 20 25 918 923 O
3 26 27 924 925 B-lower_bound
weeks 28 33 926 931 I-lower_bound
from 34 38 932 936 O
the 39 42 937 940 O
last 43 47 941 945 O
dose 48 52 946 950 O
of 53 55 951 953 O
standard 56 64 954 962 B-treatment
cytotoxic 65 74 963 972 I-treatment
chemotherapy 75 87 973 985 I-treatment
or 88 90 986 988 O
myelosuppressive 91 107 989 1005 B-treatment
biological 108 118 1006 1016 I-treatment
therapy 119 126 1017 1024 I-treatment
and 127 130 1025 1028 O
at 131 133 1029 1031 O
least 134 139 1032 1037 O
1 140 141 1038 1039 B-lower_bound
week 142 146 1040 1044 I-lower_bound
from 147 151 1045 1049 O
the 152 155 1050 1053 O
last 156 160 1054 1058 O
dose 161 165 1059 1063 O
of 166 168 1064 1066 O
non 169 172 1067 1070 B-treatment
- 172 173 1070 1071 I-treatment
myelosuppressive 173 189 1071 1087 I-treatment
biologic 190 198 1088 1096 I-treatment
therapy 199 206 1097 1104 I-treatment

Patients 0 8 1105 1113 O
must 9 13 1114 1118 O
be 14 16 1119 1121 O
free 17 21 1122 1126 O
of 22 24 1127 1129 O
systemic 25 33 1130 1138 B-chronic_disease
infection 34 43 1139 1148 I-chronic_disease
requiring 44 53 1149 1158 O
IV 54 56 1159 1161 B-treatment
antibiotics 57 68 1162 1173 I-treatment
at 69 71 1174 1176 O
the 72 75 1177 1180 O
time 76 80 1181 1185 O
of 81 83 1186 1188 O
registration 84 96 1189 1201 O

Patients 0 8 1202 1210 O
must 9 13 1211 1215 O
be 14 16 1216 1218 O
off 17 20 1219 1222 O
IV 21 23 1223 1225 B-treatment
antibiotics 24 35 1226 1237 I-treatment
for 36 39 1238 1241 O
at 40 42 1242 1244 O
least 43 48 1245 1250 O
7 49 50 1251 1252 B-upper_bound
days 51 55 1253 1257 I-upper_bound
prior 56 61 1258 1263 I-upper_bound
to 62 64 1264 1266 O
registration 65 77 1267 1279 O

Patients 0 8 1280 1288 O
must 9 13 1289 1293 O
be 14 16 1294 1296 O
≥ 17 18 1297 1298 O
12 19 21 1299 1301 B-lower_bound
months 22 28 1302 1308 I-lower_bound
and 29 32 1309 1312 O
< 33 34 1313 1314 O
22 35 37 1315 1317 B-upper_bound
years 38 43 1318 1323 I-upper_bound
of 44 46 1324 1326 O
age 47 50 1327 1330 B-age
at 51 53 1331 1333 O
the 54 57 1334 1337 O
time 58 62 1338 1342 O
of 63 65 1343 1345 O
HLA 66 69 1346 1349 O
- 69 70 1349 1350 O
A2 70 72 1350 1352 O
screening 73 82 1353 1362 O

Patients 0 8 1363 1371 O
must 9 13 1372 1376 O
have 14 18 1377 1381 O
a 19 20 1382 1383 O
performance 21 32 1384 1395 B-clinical_variable
status 33 39 1396 1402 I-clinical_variable
of 40 42 1403 1405 O
≥ 43 44 1406 1407 O
70 45 47 1408 1410 B-lower_bound

Patients 0 8 1411 1419 O
must 9 13 1420 1424 O
have 14 18 1425 1429 O
recovered 19 28 1430 1439 O
from 29 33 1440 1444 O
the 34 37 1445 1448 O
toxic 38 43 1449 1454 O
effects 44 51 1455 1462 O
of 52 54 1463 1465 O
prior 55 60 1466 1471 O
therapy 61 68 1472 1479 B-treatment
to 69 71 1480 1482 O
grade 72 77 1483 1488 O
1 78 79 1489 1490 O
or 80 82 1491 1493 O
better 83 89 1494 1500 O

Patients 0 8 1501 1509 O
must 9 13 1510 1514 O
not 14 17 1515 1518 O
have 18 22 1519 1523 O
a 23 24 1524 1525 O
history 25 32 1526 1533 O
of 33 35 1534 1536 O
, 35 36 1536 1537 O
or 37 39 1538 1540 O
currently 40 49 1541 1550 O
active 50 56 1551 1557 O
autoimmune 57 67 1558 1568 B-chronic_disease
disorders 68 77 1569 1578 I-chronic_disease
requiring 78 87 1579 1588 O
cytotoxic 88 97 1589 1598 B-treatment
or 98 100 1599 1601 O
immunosuppressive 101 118 1602 1619 B-treatment
therapy 119 126 1620 1627 I-treatment
, 126 127 1627 1628 O
or 128 130 1629 1631 O
autoimmune 131 141 1632 1642 O
disorders 142 151 1643 1652 O
with 152 156 1653 1657 O
visceral 157 165 1658 1666 O
involvement 166 177 1667 1678 O

Patients 0 8 1679 1687 O
who 9 12 1688 1691 O
have 13 17 1692 1696 O
received 18 26 1697 1705 O
prior 27 32 1706 1711 B-treatment
immunotherapy 33 46 1712 1725 I-treatment

Platelets 0 9 1726 1735 B-clinical_variable
> 10 11 1736 1737 O
100,000/µ 12 21 1738 1747 B-lower_bound
( 22 23 1748 1749 O
transfusion 23 34 1749 1760 O
independent 35 46 1761 1772 O
) 46 47 1772 1773 O

Radiation 0 9 1774 1783 B-treatment
therapy 10 17 1784 1791 I-treatment
counts 18 24 1792 1798 O
as 25 27 1799 1801 O
a 28 29 1802 1803 O
biologic 30 38 1804 1812 B-treatment
regimen 39 46 1813 1820 I-treatment

Renal 0 5 1821 1826 O
: 5 6 1826 1827 O
Serum 7 12 1828 1833 B-clinical_variable
creatinine 13 23 1834 1844 I-clinical_variable
based 24 29 1845 1850 O
on 30 32 1851 1853 O
age 33 36 1854 1857 B-age

SGPT 0 4 1858 1862 B-clinical_variable
( 5 6 1863 1864 I-clinical_variable
ALT 6 9 1864 1867 I-clinical_variable
) 9 10 1867 1868 I-clinical_variable
< 11 12 1869 1870 O
3x 13 15 1871 1873 B-upper_bound
institutional 16 29 1874 1887 I-upper_bound
normal 30 36 1888 1894 I-upper_bound

Unresectable 0 12 1895 1907 O
low 13 16 1908 1911 B-cancer
- 16 17 1911 1912 I-cancer
grade 17 22 1912 1917 I-cancer
gliomas 23 30 1918 1925 I-cancer
that 31 35 1926 1930 O
have 36 40 1931 1935 O
received 41 49 1936 1944 O
at 50 52 1945 1947 O
least 53 58 1948 1953 O
two 59 62 1954 1957 B-lower_bound
chemotherapy 63 75 1958 1970 B-treatment
/ 75 76 1970 1971 O
biologic 76 84 1971 1979 B-treatment
regimens 85 93 1980 1988 I-treatment

Use 0 3 1989 1992 O
of 4 6 1993 1995 O
immunosuppressives 7 25 1996 2014 B-treatment
within 26 32 2015 2021 O
four 33 37 2022 2026 B-upper_bound
weeks 38 43 2027 2032 I-upper_bound
prior 44 49 2033 2038 I-upper_bound
to 50 52 2039 2041 O
study 53 58 2042 2047 O
entry 59 64 2048 2053 O
or 65 67 2054 2056 O
anticipated 68 79 2057 2068 O
use 80 83 2069 2072 O
of 84 86 2073 2075 O
immunosuppressive 87 104 2076 2093 B-treatment
agents 105 111 2094 2100 I-treatment

absolute 0 8 2101 2109 B-clinical_variable
lymphocyte 9 19 2110 2120 I-clinical_variable
count 20 25 2121 2126 I-clinical_variable
of 26 28 2127 2129 O
≥ 29 30 2130 2131 O
500/µ 31 36 2132 2137 B-lower_bound

corticosteroid 0 14 2138 2152 B-treatment
for 15 18 2153 2156 O
at 19 21 2157 2159 O
least 22 27 2160 2165 O
one 28 31 2166 2169 B-upper_bound
week 32 36 2170 2174 I-upper_bound
prior 37 42 2175 2180 I-upper_bound
to 43 45 2181 2183 O
study 46 51 2184 2189 O
registration 52 64 2190 2202 O

no 0 2 2203 2205 O
more 3 7 2206 2210 O
than 8 12 2211 2215 O
0.1 13 16 2216 2219 B-lower_bound
mg 17 19 2220 2222 I-lower_bound
/ 19 20 2222 2223 I-lower_bound
kg 20 22 2223 2225 I-lower_bound
/ 22 23 2225 2226 I-lower_bound
day 23 26 2226 2229 I-lower_bound
, 26 27 2229 2230 O
max 28 31 2231 2234 O
4 32 33 2235 2236 B-upper_bound
mg 34 36 2237 2239 I-upper_bound
/ 36 37 2239 2240 I-upper_bound
day 37 40 2240 2243 I-upper_bound
Dexamethasone 41 54 2244 2257 B-treatment

radioisotope 0 12 2258 2270 B-clinical_variable
GFR 13 16 2271 2274 I-clinical_variable
≥ 17 18 2275 2276 O
70 19 21 2277 2279 B-lower_bound
ml 22 24 2280 2282 I-lower_bound
/ 24 25 2282 2283 I-lower_bound
min 25 28 2283 2286 I-lower_bound
/ 28 29 2286 2287 I-lower_bound
ml 29 31 2287 2289 I-lower_bound
/ 31 32 2289 2290 I-lower_bound
min/1.73 32 40 2290 2298 I-lower_bound
m² 41 43 2299 2301 I-lower_bound

